Clinical Trials Directory

Trials / Completed

CompletedNCT03831568

Mechanical Cough Augmentation in Children With NMD

Prevalence and Use of Mechanical Cough Augmentation in Children With Neuromuscular Disorders in Norway

Status
Completed
Phase
Study type
Observational
Enrollment
72 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study investigates the prevalence and use of mechanical insufflation - exsufflation (MI-E) in children with Neuromuscular disorders (NMD) in Norway. The NMD related prevalence of MIE use in Norway will be described and possible regional differences regarding use will be assessed.

Detailed description

Neuromuscular diseases (NMD) in children are severe, possibly life-threatening orphan conditions. Respiratory tract infections and lung complications are the main causes of increased morbidity and mortality. The use of mechanical cough augmentation with insufflation-exsufflation (MIE) is a strategy to treat and prevent. Possible major benefits are described, but optimal settings for best efficacy and comfort in children are not established. The main objective is to determine the prevalence and use of MIE among children with NMD in Norway. All children with NMD \< 18 years which has received a machine for MI-E will be invited to participate in the study. The participants will be asked to complete two questionnaires. In addition will information from the data card in the MI-E machines give information about use. The information will be linked to the National register for Long term mechanical ventilation.

Conditions

Timeline

Start date
2018-01-01
Primary completion
2019-01-31
Completion
2019-01-31
First posted
2019-02-06
Last updated
2019-09-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03831568. Inclusion in this directory is not an endorsement.